Methylphenidate effects on mice odontogenesis and connections with human odontogenesis
Authors:
- Karol Sartori LimaKLKarol Sartori Lima
- Antônio Eduardo Sparça SallesASAntônio Eduardo Sparça Salles
- Gabriel de Araújo CostaGCGabriel de Araújo Costa
- Márjori Frítola YokoyamaMYMárjori Frítola Yokoyama
- Solange de Paula RamosSRSolange de Paula Ramos
- Vanessa Rodrigues Paixão-CôrtesVPVanessa Rodrigues Paixão-Côrtes
- Renata Lúcia Leite Ferreira de LimaRLRenata Lúcia Leite Ferreira de Lima
- Maria José Sparça SallesMSMaria José Sparça Salles
- 31 August 2020
- journal article
- research article
- Published by Springer Nature in Odontology
- Vol. 109 (2) , 336-348
Abstract
The purpose of this study is to evaluate the effects of Methylphenidate exposure on mice odontogenesis and connect them by bioinformatics with human odontogenesis. Thirty-two pregnant Swiss mice were divided into treated group and control group, which received, respectively, 5 mg/kg of Methylphenidate and saline solution from the 5th to the 17th day of pregnancy. The mouse embryos tooth germs were analyzed through optical microscopy, and the data collected were analyzed statistically by Fisher’s exact test. The presence and similarity of Methylphenidate-associated genes (Pharmgkb database) in both organisms and their interaction with dental development genes (AmiGO2 database) were verified on STRING database. Rates of tooth germ malformations were higher in treated than in control group (Control: 18; Treated: 27; p = 0.035). Mouse embryo malformations were connected with 238 interactions between 69 dental development genes with 35 Methylphenidate genes. Fourteen interactions for four Methylphenidate genes with four dental development genes, with human experimental data, were connected with mouse phenotype data. By homology, the interactions and conservation of proteins/genes may indicate similar outcomes for both organisms. The exposure to Methylphenidate during pregnancy affected odontogenesis in mouse embryos and may affect human odontogenesis. The study of malformations in mice, with a bioinformatics approach, could contribute to understanding of the Methylphenidate effect on embryo development. These results may provide novel hypotheses for further testing and reinforce the FDA protocol: as Methylphenidate is included in category C, its use during pregnancy should be considered if the benefits outweigh the risks.Keywords
This publication has 31 references indexed in Scilit:
- Current understanding of the process of tooth formation: transfer from the laboratory to the clinicAustralian Dental Journal, 2013
- Evaluation of Escitalopram, Sertraline, and Methylphenidate in the Immature Rat Uterotrophic AssayInternational Journal of Toxicology, 2013
- Norepinephrine Genes Predict Response Time Variability and Methylphenidate-Induced Changes in Neuropsychological Function in Attention Deficit Hyperactivity DisorderJournal of Clinical Psychopharmacology, 2013
- Analysis Tool Web Services from the EMBL-EBINucleic Acids Research, 2013
- First Trimester In Utero Exposure to MethylphenidateBasic & Clinical Pharmacology & Toxicology, 2013
- The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspectiveEuropean Journal of Clinical Pharmacology, 2012
- Smad4-Shh-Nfic signaling cascade–mediated epithelial-mesenchymal interaction is crucial in regulating tooth root developmentJournal of Bone and Mineral Research, 2010
- Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Heterotrimeric G proteins precouple with G protein-coupled receptors in living cellsProceedings of the National Academy of Sciences, 2005
- Prenatal exposure to methylphenidate hydrochloride decreases anxiety and increases exploration in micePharmacology Biochemistry and Behavior, 2004